Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™
Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) — Regen BioPharma, Inc. (OTC…
Pharmaceuticals, Biotechnology and Life Sciences
Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) — Regen BioPharma, Inc. (OTC…
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced…
MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on…
SOUTH SAN FRANCISCO, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical…
DENVER, Nov. 19, 2024 (GLOBE NEWSWIRE) — The 13th annual MJBizCon, the largest, most established cannabis business conference and expo in the…
IRVINE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) — Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in…
ORION CORPORATION INVESTOR NEWS 19 NOVEMBER 2024 at 18.30 EET Orion and Alligator Bioscience amend their agreement concerning…
The waste carbon-to-ethanol facility will transform Henan Energy Group’s on-site waste gases into 50,000 tons of ethanol per year Sylonto…
Company appoints Anil K. Sood, MD, as inaugural member Company continues to advance lead program, KAD101 for the treatment of…
Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce developmentMonrovia,…